3000 tumor samples could unlock secrets of drug resistance
NCT ID NCT03572192
First seen Nov 18, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study aims to collect tumor and blood samples from 3000 adults with solid tumors to learn why cancers become resistant to treatments and spread. Researchers will use advanced lab tests to find molecular clues. The goal is to develop better treatments and tests for individual patients. No new treatments are given; only leftover tissue from routine procedures is used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOURS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St Bartholomew's Hospital
RECRUITINGLondon, EC1A 7BE, United Kingdom
Contact
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.